MicroRNA-200 Family and Endometrial Carcinoma
Author Information
Author(s): Jaime Snowdon, Xiao Zhang, Tim Childs, Victor A. Tron, Harriet Feilotter
Primary Institution: Queen's University and Kingston General Hospital
Hypothesis
The study aims to identify dysregulated microRNAs in endometrioid endometrial adenocarcinoma and its precursor lesion.
Conclusion
The study found that the entire miR-200 family is upregulated in endometrial carcinoma, suggesting its role in tumorigenesis.
Supporting Evidence
- Forty-three miRNAs were found to be dysregulated in endometrial carcinoma and complex atypical hyperplasia compared to normal controls.
- The entire miR-200 family was significantly upregulated in endometrial carcinoma cases.
- The study utilized Agilent Human miRNA arrays for expression profiling.
Takeaway
This study looked at tiny molecules called microRNAs in cancer and found that a specific group, the miR-200 family, is more active in a type of uterine cancer.
Methodology
The study compared the expression of 723 human miRNAs from 14 cases of endometrial carcinoma, 10 cases of complex atypical hyperplasia, and 10 normal controls using microarrays.
Limitations
The study did not have a sufficiently large sample size to detect differences between lower grade and higher grade tumors.
Participant Demographics
Participants included women with endometrial carcinoma and complex atypical hyperplasia, with a median age of 60.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website